Screener
PJP vs KAUG
Invesco Pharmaceuticals ETF vs Innovator U.S. Small Cap Power Buffer ETF - August
Key differences
- PJP costs 0.22% less per year.
- PJP is significantly larger than KAUG — larger funds tend to be more liquid and less likely to close.
- PJP is classified as equity, while KAUG is alternative — different risk/return profiles.
- PJP follows a index tracking strategy; KAUG uses structured outcome.
- PJP has a longer track record, which may reduce uncertainty around long-term behavior.
Side-by-side comparison
| PJP | KAUG | |
|---|---|---|
| Annual cost (TER) | 0.57% | 0.79% |
| Fund size (AUM) | $334M | $80M |
| Since | 2005 | 2024 |
| Dividend yield | 1.01% | 0.00% |
| Asset class | equity | alternative |
| Region | north america | north america |
| Strategy | index tracking | structured outcome |
| CAGR 1Y | +40.6% | +17.0% |
| CAGR 3Y | +14.0% | N/A |
| CAGR 5Y | +7.8% | N/A |
| Sharpe 3Y | 0.69 | N/A |
| Volatility 1Y | 16.23% | 8.09% |
| Max drawdown | -33.95% | -15.66% |
Green dot indicates the better value for that metric. Performance data is historical and does not predict future results.
Similar to PJP and KAUG
Explore further